NCT06460454View on ClinicalTrials.gov

PROnostic Interest of 18F-FDG PET/CT in Patients With Metastatic Castration-resistant Prostate Cancer (mCPRC) Progressing

CompletedOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

January 1, 2025

Study Completion Date

February 25, 2025

Conditions

Prostate Cancer

Interventions

DEVICE

PET scan of 18F-FDG

VEREOS PET scanner. Philips VEREOS digital PET-CT scanners are installed in the nuclear medicine department.

Trial Locations (1)

54511

Nuclear medicine Department CHRU de NANCY, Vandœuvre-lès-Nancy

All Listed Sponsors

lead

Central Hospital, Nancy, France

OTHER

NCT06460454 - PROnostic Interest of 18F-FDG PET/CT in Patients With Metastatic Castration-resistant Prostate Cancer (mCPRC) Progressing | Biotech Hunter | Biotech Hunter